Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT1B receptors

被引:6
作者
Berg, KA [1 ]
Evans, KLJ [1 ]
Cropper, JD [1 ]
Clarke, WP [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA
关键词
D O I
10.1124/jpet.102.042564
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Coactivation of purinergic (P-2Y) receptors reduces agonist efficacy at serotonin(1B) (5-HT1B), but not 5-HT1A receptors. Herein, we report that pretreatment for 5 min with the P-2Y receptor agonist ATP reduced agonist responsiveness at the 5-HT1A, but not at the 5-HT1B, receptor. The effect of ATP pretreatment on the 5-HT1A receptor response rapidly reversed within a 10 min time frame between P-2Y receptor and 5-HT1A receptor activation. ATP pretreatment effects on 5-HT1A agonist responsiveness were blocked by the protein kinase inhibitors staurosporine and bisindolylmaleimide, suggesting that the ATP-mediated temporal regulation involves activation of protein kinase C (PKC). Moreover, the temporal effect of ATP was blocked by incubation with 1% ethanol, suggesting that consequences of phospholipase D (PLD) activation play a role. ATP pretreatment blocked the inhibitory effect produced by 5-HT2C receptor activation on the 5-HT1A, but not the 5-HT1B, receptor response, suggesting that the 5-HT1A receptor itself was the target for PLD/PKC action. Finally, ethanol did not block the reduction in responsiveness of the 5-HT1A receptor system produced by activation of PKC with phorbol ester treatment, suggesting that PKC activation lies downstream of PLD. Taken together, these data suggest that activation of P-2Y receptors can reduce responsiveness of the 5-HT1A receptor system via a PLD/PKC-dependent mechanism that is highly dependent upon the temporal pattern of receptor activation. Moreover, this work underscores the importance of time as a variable in receptor signaling cross talk and serves to further illustrate differences between the 5-HT1A and 5-HT1B receptor systems.
引用
收藏
页码:200 / 205
页数:6
相关论文
共 32 条
[1]  
ADHAM N, 1992, MOL PHARMACOL, V41, P1
[2]   The 5HT1A receptor: Signaling, desensitization, and gene transcription [J].
Albert, PR ;
Lembo, P ;
Storring, JM ;
Charest, A ;
Saucier, C .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (01) :19-25
[3]  
BERG KA, 1994, MOL PHARMACOL, V45, P826
[4]  
Berg KA, 1999, MOL PHARMACOL, V55, P863
[5]  
BERG KA, 1994, MOL PHARMACOL, V46, P477
[6]   Interactions between effectors linked to serotonin receptors [J].
Berg, KA ;
Maayani, S ;
Clarke, WP .
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 :111-120
[7]  
Berg KA, 1996, MOL PHARMACOL, V50, P1017
[8]   Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders [J].
Blier, P ;
de Montigny, C .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S91-S98
[9]   5-HT1B RECEPTORS ARE NEGATIVELY COUPLED WITH ADENYLATE-CYCLASE IN RAT SUBSTANTIA NIGRA [J].
BOUHELAL, R ;
SMOUNYA, L ;
BOCKAERT, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (02) :189-196
[10]   THE CLONED VASOPRESSIN V1A RECEPTOR STIMULATES PHOSPHOLIPASE A(2), PHOSPHOLIPASE-C, AND PHOSPHOLIPASE-D THROUGH ACTIVATION OF RECEPTOR-OPERATED CALCIUM CHANNELS [J].
BRILEY, EM ;
LOLAIT, SJ ;
AXELROD, J ;
FELDER, CC .
NEUROPEPTIDES, 1994, 27 (01) :63-74